DIANA ALVIZO: Open Payments
NPI 1760180970 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 26 payments from 5 companies in 2025. Trend: 2023 $462 · 2024 $549 · 2025 $572
Food & beverage: $397Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $393 |
| Novo Nordisk Inc | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Corcept Therapeutics | 1 | $28 |
| Medtronic, Inc. | 1 | $16 |
Products named: PROLIA, OTEZLA, Wegovy, JARDIANCE, REPATHA, Korlym, MINIMED 780G, TEZSPIRE.
Industry payments across CA — which companies pay providers there.
